Great to hear some news in relation to the future strategic direction of the company
Cash and liquid asset position of 21.5 cents/share is great comapred to the current share price.
Moybdenum prices are still low so doubt if that is going to go progress in the short term but apears that in the long term the BOard sees that it is worth hanging onto the resource.
Trouble is with this stock is that it might take a while for investor interest to return and drive the price upwards
Great to hear some news in relation to the future strategic...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
